UTHR
UTHR clinical trials: UNITED THERAPEUTICS Corp
Every trial on ClinicalTrials.gov where UNITED THERAPEUTICS Corp is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 119
- Trials linked
- 85
- As lead sponsor
- 34
- As collaborator
- 1
- Primary completions as lead sponsor, next 90 days
UTHR on the catalyst calendar · UTHR registry changes
- Primary completion May 2028Sponsor estimatePhase 2NCT07923591Study of Treprostinil Administered Via Soft Mist Inhaler (SMI) in Participants With Pulmonary Hypertension Associated With Chronic...United Therapeutics · Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary DiseaseNot yet recruitingUTHRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2034Sponsor estimatePhase 2/Phase 3NCT07923526An Open-Label Extension Study to Evaluate Inhaled Treprostinil SMI in Participants With Pulmonary Hypertension Associated With Chronic...United Therapeutics · Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary DiseaseNot yet recruitingUTHRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2029Sponsor estimatePhase 3NCT04905693Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung DiseaseUnited Therapeutics · Idiopathic Pulmonary FibrosisEnrolling by invitationUTHRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2026Sponsor estimatePhase 3NCT03683186A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionUnited Therapeutics · PAHEnrolling by invitationUTHRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 30, 2025ActualPhase 3NCT05255991Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary FibrosisUnited Therapeutics · Idiopathic Pulmonary FibrosisCompletedUTHRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2029Sponsor estimatePhase 1/Phase 2NCT07224763Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRDUnited Therapeutics · ESRD (End-Stage Renal Disease)RecruitingUTHRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 1, 2030Sponsor estimateNo phase registeredNCT06388421DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)United Therapeutics · Pulmonary Hypertension Due to Lung Diseases and HypoxiaRecruitingUTHRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2027Sponsor estimatePhase 3NCT05943535Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)United Therapeutics · Progressive Pulmonary FibrosisRecruitingUTHRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2025ActualPhase 3NCT03626688A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH PatientsUnited Therapeutics · PAHCompletedUTHRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 12, 2023ActualPhase 3NCT04084678Study of Ralinepag on Exercise Capacity by Cardiopulmonary Exercise Testing (CPET) in WHO Group 1 PH SubjectsUnited Therapeutics · Pulmonary HypertensionTerminatedUTHRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 13, 2026ActualNo phase registeredNCT05776225Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier DetectionUnited Therapeutics · Interstitial Lung DiseaseCompletedUTHRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 29, 2022ActualPhase 3NCT03794583Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)United Therapeutics · Pulmonary HypertensionTerminatedUTHRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 2, 2026ActualPhase 3NCT04708782Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary FibrosisUnited Therapeutics · Idiopathic Pulmonary FibrosisCompletedUTHRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 2027Sponsor estimateNo phase registeredNCT03045029ADAPT - A Patient Registry of the Real-world Use of Orenitram®United Therapeutics · Pulmonary Arterial HypertensionActive, not recruitingUTHRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2028Sponsor estimatePhase 1/Phase 2NCT06878560Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRDUnited Therapeutics · ESRD (End-Stage Renal Disease)RecruitingUTHRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 30, 2026Sponsor estimatePhase 4NCT05203510A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular...United Therapeutics · Pulmonary Arterial HypertensionActive, not recruitingUTHRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jul 20, 2017ActualPhase 2NCT02276872Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 YearsUnited Therapeutics · PAHCompletedUTHRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2024ActualNo phase registeredNCT05060315Evaluate Real-World Use of Next Generation Infusion Pumps to Administer RemodulinUnited Therapeutics · Pulmonary Arterial HypertensionTerminatedUTHRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 22, 2023ActualPhase 1NCT03950739Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using TyvasoUnited Therapeutics · Pulmonary Arterial HypertensionCompletedUTHRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2011ActualPhase 2NCT00848107Open-Label Study of Oral Treprostinil in Digital UlcersUnited Therapeutics · Systemic SclerosisTerminatedUTHRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 27, 2022ActualPhase 2NCT02261883Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the NewbornUnited Therapeutics · Persistent Pulmonary Hypertension of the NewbornTerminatedUTHRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 25, 2014ActualPhase 4NCT03055221TRUST-2: Safety and Efficacy of Intravenous Remodulin® in Patients in India With Pulmonary Arterial Hypertension (PAH)United Therapeutics · Pulmonary Arterial HypertensionCompletedUTHRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2013ActualPhase 3NCT01934582A Pharmacokinetic Substudy of the TDE-PH-304 ProtocolUnited Therapeutics · Pulmonary Arterial HypertensionCompletedUTHRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jun 2010Sponsor estimatePhase 2/Phase 3NCT01884038Safety and Efficacy of Perioperative Remodulin® in Orthotopic Liver Transplant RecipientsUnited Therapeutics · Liver TransplantWithdrawnUTHRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 2010ActualPhase 4NCT00643604Rapid Switch From Flolan to Remodulin in the Outpatient ClinicUnited Therapeutics · Hypertension, PulmonaryTerminatedUTHRLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 trials. There are 94 more in this window; the full list is part of TrialScanner.
Unlock with TrialScanner